Skip to content
★ Sign in to follow
Total declarations
15
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (4 ops.)
€1.8M

Latest filing published 13 Feb 2019 for Enanta Pharmaceuticals INC, €361k.

Filing timeline

BuySale
Tim Ocain

Insider track record

Disclosed buys
0
Disclosed sells
4
Signal history

Tim Ocain: trading record in brief

All filings by Tim Ocain on record concern Enanta Pharmaceuticals Inc. In total, 15 filings cover trades dated from 13 February 2017 to 12 February 2019.

No open-market purchase appears, only 4 sales worth €1.8M. Other entries cover 8 share grants and 3 option exercises.

The record was last updated on 13 February 2019 with a share grant (€361k) in Enanta Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Tim Ocain

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total

15 of 15 declarations